Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oculentis was a private ophthalmic medical device company focused on the design, manufacture, and commercialization of premium intraocular lenses for cataract and refractive surgery. The company operated R&D activities in Berlin and manufacturing in Eerbeek, the Netherlands, and was known for its LENTIS family of intraocular lenses, including multifocal, toric, and presbyopia-correcting products. Oculentis positioned itself as an independent IOL manufacturer with proprietary lens designs such as the rotationally asymmetric LENTIS Mplus platform. The company encountered major legal and product-safety issues related to certain lenses and entered bankruptcy proceedings in the Netherlands in September 2021. Its product franchise and personnel were subsequently associated in the market with Teleon Surgical, but the available evidence does not support characterizing Oculentis itself as an acquired company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oculentis.